Benzinga - Gainers
- IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
- Avaya Holdings Corp. (NYSE: AVYA) gained 57% to $0.2384.
- Athenex, Inc. (NASDAQ: ATNX) surged 47% to $0.1991 after the company announced Quantum Leap Healthcare Collaborative reported a trial result of I-SPY2 trial for oral paclitaxel in combination with PD-1 and carboplatin in neoadjuvant breast cancer.
- Verona Pharma plc (NASDAQ: VRNA) shares climbed 40.5% to $18.71 after the company announced ensifentrine met primary and key secondary endpoints in the Phase 3 ENHANCE-1 trial for COPD.
- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares climbed 33.9% to $0.4194. Vallon Pharmaceuticals and GRI Bio recently announced they entered into a merger agreement.
- Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) surged 29.7% to $25.95.
- IAMGOLD Corporation (NYSE: IAG (LON:ICAG)) gained 26.9% to $2.31 after the company announced a transaction with Sumimoto Metal Mining to provide up to $340 million in additional funding to the contruction of the Côté Gold Project. Also, the company announced an agreement to sell its Boto Gold Project and surrounding exploration assets to Managem for a total consideration of $282 million.
- United Insurance Holdings Corp. (NASDAQ: UIHC) gained 24.7% to $0.6256. United Insurance Holdings Chief Operating Officer Christopher Griffith bought a total of 20,000 shares at an average price of $0.57.
- Acasti Pharma Inc. (NASDAQ: ACST) jumped 22.5% to $0.4899.
- Alset Inc. (NASDAQ: AEI) jumped 22% to $0.1849.
- Core Scientific, Inc. (NASDAQ: CORZ) gained 21.7% to $0.2463.
- Baudax Bio, Inc. (NASDAQ: BXRX) rose 20.7% to $2.22. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
- Smart for Life, Inc. (NASDAQ: SMFL) rose 20.5% to $0.2415 after dropping 22% on Monday.
- Exicure, Inc. (NASDAQ: XCUR) shares gained 18.9% to $0.88. Exicure 10% owner CBI USA, Inc. acquired a total of 3,400,000 shares at an average price of $1.60.
- Appreciate Holdings, Inc. (NASDAQ: SFR) gained 18.4% to $1.48.
- MediaAlpha, Inc. (NYSE: MAX) gained 17.5% to $18.71. JP Morgan upgraded MediaAlpha from Neutral to Overweight and raised the price target from $12 to $14.
- Pagaya Technologies Ltd. (NASDAQ: PGY) rose 17.2% to $0.6705.
- EverQuote, Inc. (NASDAQ: EVER) shares climbed 15.4% to $18.71 after JPMorgan (NYSE:JPM) upgraded the stock from Underweight to Overweight and raised its price target from $8 to $15.
- Hycroft Mining Holding Corporation (NASDAQ: HYMC) gained 15.2% to $0.5245.
- Taseko Mines Limited (NYSE: TGB) gained 14.8% to $1.4358 after the company announced it formed a strategic partnershi with Mitsui to develop the company's Florence Copper project.
- Surrozen, Inc. (NASDAQ: SRZN) rose 14.5% to $0.55 after gaining 8% on Monday.
- Mitsubishi UFJ Financial Group, Inc. (NYSE: MUFG) rose 14.3% to $6.34.
- Landos Biopharma, Inc. (NASDAQ: LABP) gained 14.3% to $0.4710.
- DLocal Limited (NASDAQ: DLO) gained 14% to $15.03 after the company refuted a short-seller report and announced a share buyback program and proposed share purchases by key share holders.
- Metacrine, Inc. (NASDAQ: MTCR) rose 13.6% to $0.3980. Tang Capital Partners reported in 13G filing a 7.1% stake in Metacrine.
- Natura &Co Holding S.A. (NYSE: NTCO) gained 12.6% to $4.37.
- Sumitomo Mitsui Financial Group, Inc. (NYSE: SMFG) rose 12.2% to $7.70.
- Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) gained 11.7% to $2.68.
- Steelcase Inc. (NYSE: SCS) gained 11.6% to $6.98 after the company announced better-than-expected Q3 EPS results.
- New Pacific Metals Corp. (NYSE: NEWP) jumped 11.4% to $2.4350.
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) gained 11.3% to $0.5475.
- TAL Education Group (NYSE: TAL) rose 11.3% to $9.02.
- Coeur Mining, Inc. (NYSE: CDE) gained 8.7% to $3.41.
- Caravelle International Group (NASDAQ: CACO) shares dipped 57.9% to $2.03 after declining over 12% on Monday.
- Magenta Therapeutics, Inc. (NASDAQ: MGTA) dropped 44% to $0.4650 after the company reported it stopped dosing participants at the Cohort 4 dosing level and plans to dose additional participants at the Cohort 3 dosing level due to dose-limiting toxicities.
- Entrada Therapeutics Inc (NASDAQ: TRDA) fell 33.5% to $13.22 after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.
- Axcella Health Inc. (NASDAQ: AXLA) shares fell 29.1% to $0.3048 after gaining 165% on Monday. Axcella Health recently announced organizational and program updates, including a reprioritization of its programs for Long COVID Fatigue and Nonalcoholic Steatohepatitis (NASH) and a restructuring of operations.
- Arcus Biosciences, Inc. (NYSE: RCUS) fell 28.1% to $21.92. Gilead Sciences (NASDAQ:GILD) and Arcus Biosciences announced results from the fourth interim analysis of the ARC-7 Phase 2 study for metastatic non-small cell lung cancer with PD-L1 tumor proportion score ≥50% without epidermal growth factor receptor or anaplastic lymphoma kinase mutations.
- BioVie Inc. (NASDAQ: BIVI) fell 27% to $7.27.
- Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares fell 26.3% to $1.3599. Soleno Therapeutics shares jumped around 104% on Monday after the company announced a financing commitment for up to $60 million..
- AppTech Payments Corp. (NASDAQ: APCX) fell 24.4% to $1.0583 after jumping 55% on Monday.
- Kineta Inc (NASDAQ: KA) fell 24.4% to $3.76.
- Cosmos Health Inc. (NASDAQ: COSM) dropped 22% to $5.91. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.
- Prenetics Global Limited (NASDAQ: PRE) fell 20.4% to $1.91.
- Camber Energy, Inc. (NYSE: CEI) fell 20% to $0.0857. Camber Energy shares jumped 73% on Monday after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) fell 18.2% to $0.1451 after dropping 13% on Monday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
- Agrify Corporation (NASDAQ: AGFY) dropped 17.8% to $0.2750.
- NantHealth, Inc. (NASDAQ: NH) shares fell 17.4% to $3.4801 after dropping 26% on Monday. NantHealth recently announced a 1-for-15 reverse stock split.
- WaveDancer, Inc. (NASDAQ: WAVD) dipped 15.7% to $0.3975.
- Duos Technologies Group, Inc. (NASDAQ: DUOT) dropped 14.9% to $2.05.
- Embecta Corp. (NASDAQ: EMBC) fell 14.8% to $27.65 after the company reported a decline in Q4 sales.
- Vigil Neuroscience, Inc. (NASDAQ: VIGL) dropped 14.5% to $10.51.
- MicroAlgo Inc. (NASDAQ: MLGO) declined 14.3% to $1.44.
- Mullen Automotive, Inc. (NASDAQ: MULN) fell 14.1% to $0.2330.
- Leju Holdings Limited (NYSE: LEJU) dropped 13.5% to $1.35.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) fell 13.4% to $0.3031.
- Ark Restaurants Corp. (NASDAQ: ARKR) dropped 13.1% to $15.74 after the company reported a sharp decline in quarterly earnings.
- Embecta Corp. (NASDAQ: EMBC) fell 12.4% to $28.47 after the company reported Q4 earnings results.
- ioneer Ltd (NASDAQ: IONR) dropped 12.3% to $11.96.
- Reed's, Inc. (NASDAQ: REED) fell 12% to $0.0889 after gaining around 35% on Monday.
- Otonomy, Inc (NASDAQ: OTIC) fell 9.6% to $0.1037. Otonomy's board of directors has approved and adopted a Plan of Liquidation and Dissolution that would include the distribution of remaining cash to stockholders following an orderly wind-down of the company's operations, including the proceeds from the sale of any pipeline assets.
- Hoth Therapeutics, Inc. (NASDAQ: HOTH) fell 9.5% to $2.68 after dropping 14% on Monday. Hoth Therapeutics recently announced submission of investigational new drug application for HT-001.
- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares fell 8.7% to $0.7518 after jumping 49% on Monday.
- Sintx Technologies, Inc. (NASDAQ: SINT) dropped 7% to $7.25. Sintx Technologies announced a 1-for-100 reverse stock split, effective December 20, 2022.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.